Understand the key differences between osteoporosis and rheumatoid arthritis clinical trials and research opportunities
Affects ~3 million in the UK, predominantly post-menopausal women. Anabolic agents (romosozumab) and novel bisphosphonates drive trial activity.
Autoimmune joint condition affecting ~400,000. Biologic and targeted synthetic DMARDs are the mainstay of clinical research.
Osteoporosis trials focus on fracture reduction. RA trials target disease remission and joint preservation. Both affect bone health but through different mechanisms.
Search our database of 29,000+ UK clinical trials matched to your condition and profile
Browse Disease PathwaysData sourced from ClinicalTrials.gov. Trial counts are approximate and updated regularly.
TrialConnect is a trading name of Clinical Vendor Compare Limited.